Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...

Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Q2 2025 Results Conference Call July 17, 2025 9:00 AM ETCompany ParticipantsMichael Comilla - Vice President of ...

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see ...

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.